CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade PAVmed Inc. - PAVM CFD

    Market is not available at the moment

    Market information is presented
    as of 2023-09-21

    • Summary
    Trading Conditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    PAVmed Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.47
    Open* 0.46
    1-Year Change* -61.98%
    Day's Range* 0.39 - 0.48
    52 wk Range 0.21-1.32
    Average Volume (10 days) 914.41K
    Average Volume (3 months) 11.90M
    Market Cap 55.49M
    P/E Ratio -100.00K
    Shares Outstanding 111.42M
    Revenue 800.00K
    EPS -0.84
    Dividend (Yield %) N/A
    Beta 0.72
    Next Earnings Date Nov 13, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    Date Close Change Change (%) Open High Low
    Sep 12, 2023 0.39 -0.07 -15.22% 0.46 0.49 0.39
    Sep 11, 2023 0.47 0.02 4.44% 0.45 0.57 0.45
    Sep 8, 2023 0.44 -0.04 -8.33% 0.48 0.48 0.41
    Sep 7, 2023 0.47 0.07 17.50% 0.40 0.48 0.40
    Sep 6, 2023 0.40 0.01 2.56% 0.39 0.44 0.39
    Sep 5, 2023 0.39 0.01 2.63% 0.38 0.40 0.38
    Jul 21, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
    Jul 20, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
    Jul 19, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
    Jul 13, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
    Jul 12, 2023 0.38 -0.01 -2.56% 0.39 0.40 0.37
    Jul 11, 2023 0.40 0.02 5.26% 0.38 0.41 0.38
    Jul 5, 2023 0.38 -0.01 -2.56% 0.39 0.39 0.38
    Jul 3, 2023 0.39 0.01 2.63% 0.38 0.39 0.38
    Jun 30, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
    Jun 29, 2023 0.38 0.00 0.00% 0.38 0.39 0.38
    Jun 21, 2023 0.38 0.00 0.00% 0.38 0.39 0.38
    Jun 20, 2023 0.39 0.00 0.00% 0.39 0.40 0.38
    Jun 16, 2023 0.40 0.01 2.56% 0.39 0.41 0.38
    Jun 15, 2023 0.40 0.02 5.26% 0.38 0.40 0.38

    PAVmed Inc. Events

    Time (UTC) Country Event
    Monday, November 13, 2023

    Time (UTC)

    21:00

    Country

    US

    Event

    Q3 2023 PAVmed Inc Earnings Release
    Q3 2023 PAVmed Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.377 0.5 0 0 0
    Revenue 0.377 0.5 0 0 0
    Total Operating Expense 96.738 58.308 29.848 16.1266 11.9715
    Selling/General/Admin. Expenses, Total 59.686 34.235 12.388 7.66497 6.30532
    Research & Development 25.547 19.847 10.963 6.63033 4.2481
    Operating Income -96.361 -57.808 -29.848 -16.1266 -11.9715
    Net Income Before Taxes -103.238 -56.126 -35.888 -17.2681 -18.1728
    Net Income After Taxes -103.238 -56.126 -35.888 -17.2681 -18.1728
    Net Income Before Extra. Items -88.983 -50.347 -34.276 -16.4572 -17.9688
    Net Income -88.983 -50.347 -34.276 -16.4572 -17.9688
    Income Available to Common Excl. Extra. Items -89.264 -50.63 -34.563 -16.7271 -18.7508
    Income Available to Common Incl. Extra. Items -89.264 -50.63 -34.563 -16.7271 -18.7508
    Diluted Net Income -89.264 -50.63 -34.563 -16.7271 -18.7508
    Diluted Weighted Average Shares 89.0761 77.5158 47.4321 30.1975 22.2764
    Diluted EPS Excluding Extraordinary Items -1.00211 -0.65316 -0.72868 -0.55393 -0.84174
    Diluted Normalized EPS -0.94111 -0.6091 -0.59171 -0.49328 -0.77852
    Unusual Expense (Income) 5.434 3.415 6.497 1.83132 1.4083
    Interest Income (Expense), Net Non-Operating -2.545 1.682 -5.38 -0.59127 -5.58638
    Other, Net -4.332 -0.66 -0.55025 -0.61494
    Total Extraordinary Items
    Total Adjustments to Net Income -0.281 -0.283 -0.287 -0.2699 -0.78205
    Depreciation / Amortization 2.457 0.226 0.00979
    Minority Interest 14.255 5.779 1.612 0.81089 0.20407
    Cost of Revenue, Total 3.614 0.585
    Gross Profit -3.237 -0.085
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.166 0.446 0.112 0.076 0
    Revenue 0.166 0.446 0.112 0.076 0
    Total Operating Expense 17.393 21.372 24.927 28.512 23.484
    Selling/General/Admin. Expenses, Total 10.991 14.557 15.818 15.056 16.094
    Research & Development 3.469 4.439 6.674 6.202 6.74
    Unusual Expense (Income) 0.743 0.525 0.311 5.123 0
    Operating Income -17.227 -20.926 -24.815 -28.436 -23.484
    Interest Income (Expense), Net Non-Operating -0.665 -1.102 0.243 -0.264 -0.516
    Net Income Before Taxes -17.892 -22.214 -24.572 -29.932 -29.101
    Net Income After Taxes -17.892 -22.214 -24.572 -29.932 -29.101
    Minority Interest 3.355 4.283 4.112 3.806 3.576
    Net Income Before Extra. Items -14.537 -17.931 -20.46 -26.126 -25.525
    Net Income -14.537 -17.931 -20.46 -26.126 -25.525
    Total Adjustments to Net Income -0.075 -0.074 -0.072 -0.071 -0.07
    Income Available to Common Excl. Extra. Items -14.612 -18.005 -20.532 -26.197 -25.595
    Income Available to Common Incl. Extra. Items -14.612 -18.005 -20.532 -26.197 -25.595
    Diluted Net Income -14.612 -18.005 -20.532 -26.197 -25.595
    Diluted Weighted Average Shares 104.35 97.0952 93.1319 89.7589 86.9574
    Diluted EPS Excluding Extraordinary Items -0.14003 -0.18544 -0.22046 -0.29186 -0.29434
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.13291 -0.19033 -0.21712 -0.23478 -0.29434
    Other, Net 0 -1.186 0 -1.232 -5.101
    Cost of Revenue, Total 1.685 1.346 1.618 1.626 0
    Gross Profit -1.519 -0.9 -1.506 -1.55 0
    Depreciation / Amortization 0.505 0.505 0.506 0.505 0.65
    Gain (Loss) on Sale of Assets 0 1 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 43.926 82.637 18.941 6.54752 8.46016
    Cash and Short Term Investments 42.749 77.971 17.518 6.25335 8.23637
    Cash 39.744 77.258 17.256 6.21923 8.22212
    Cash & Equivalents 3.005 0.713 0.262 0.03412 0.01425
    Prepaid Expenses 1.101 4.032 0.644 0.29417 0.22379
    Total Assets 53.98 86.976 19.778 7.24045 8.49643
    Property/Plant/Equipment, Total - Net 5.488 1.585 0.03627
    Property/Plant/Equipment, Total - Gross 6.296 1.723 0.05696
    Accumulated Depreciation, Total -0.808 -0.138 -0.02069
    Other Long Term Assets, Total 1.121 0.725 0.837 0.69294
    Total Current Liabilities 41.2 7.558 20.251 11.8786 10.9726
    Accounts Payable 2.704 3.299 2.966 2.35281 1.73884
    Accrued Expenses 3.705 4.259 2.325 1.38677 1.33075
    Notes Payable/Short Term Debt 34.791 0 14.96 8.139 7.903
    Total Liabilities 63.661 25.31 17.882 11.0643 10.8111
    Total Long Term Debt 0 0 0 0 0
    Total Equity -9.681 61.666 1.896 -3.82385 -2.31464
    Preferred Stock - Non Redeemable, Net 2.695 2.419 2.537 2.29644 2.03185
    Common Stock 0.095 0.086 0.064 0.04048 0.02714
    Additional Paid-In Capital 216.106 198.071 87.57 47.554 32.6193
    Retained Earnings (Accumulated Deficit) -228.169 -138.91 -88.275 -53.7147 -36.9929
    Total Liabilities & Shareholders’ Equity 53.98 86.976 19.778 7.24045 8.49643
    Total Common Shares Outstanding 94.5105 86.3679 63.8199 40.4789 27.143
    Other Current Liabilities, Total 0
    Long Term Debt 0
    Total Preferred Shares Outstanding 1.20576 1.11392 1.22808 1.15821 0
    Minority Interest 20.615 17.752 -2.369 -0.81428 -0.16151
    Other Current Assets, Total 0.059 0.434 0.779
    Total Receivables, Net 0.017 0.2
    Accounts Receivable - Trade, Net 0.017 0.2
    Intangibles, Net 3.445 2.029
    Other Liabilities, Total 1.846
    Treasury Stock - Common -0.408
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 53.841 43.926 61.979 70.815 71.002
    Cash and Short Term Investments 52.81 42.749 60.765 68.47 67.71
    Cash 49.28 39.744 56.785 65.153 64.737
    Prepaid Expenses 0.977 1.101 1.128 2.13 2.937
    Total Assets 65.286 53.98 72.465 82.454 84.334
    Other Long Term Assets, Total 1.079 1.121 1.083 1.725 0.695
    Total Current Liabilities 50.546 41.2 41.911 38.867 17.493
    Accounts Payable 1.258 2.704 2.454 4.492 8.235
    Accrued Expenses 3.724 3.705 2.93 2.932 3.498
    Notes Payable/Short Term Debt 45.564 34.791 36.527 30.443 0.873
    Total Liabilities 87.343 63.661 63.517 60.476 38.403
    Total Long Term Debt 0 0 0 0 0
    Minority Interest 32.861 20.615 19.608 19.426 18.802
    Total Equity -22.057 -9.681 8.948 21.978 45.931
    Preferred Stock - Non Redeemable, Net 2.767 2.695 2.624 2.554 2.486
    Common Stock 0.101 0.095 0.092 0.087 0.087
    Additional Paid-In Capital 221.247 216.106 214.278 201.327 199.719
    Retained Earnings (Accumulated Deficit) -246.172 -228.169 -207.638 -181.442 -155.849
    Total Liabilities & Shareholders’ Equity 65.286 53.98 72.465 82.454 84.334
    Total Common Shares Outstanding 100.596 94.5105 92.2289 87.0232 86.9117
    Total Preferred Shares Outstanding 1.20576 1.20576 1.1821 1.15895 1.13621
    Total Receivables, Net 0.027 0.017 0.031 0 0.089
    Accounts Receivable - Trade, Net 0.027 0.017 0.031 0 0.089
    Total Inventory
    Property/Plant/Equipment, Total - Net 7.426 5.488 5.453 5.458 5.017
    Intangibles, Net 2.94 3.445 3.95 4.456 7.62
    Cash & Equivalents 3.53 3.005 3.98 3.317 2.973
    Other Current Assets, Total 0.027 0.059 0.055 0.215 0.266
    Other Current Liabilities, Total 1 4.887
    Other Liabilities, Total 3.936 1.846 1.998 2.183 2.108
    Treasury Stock - Common 0 -0.408 -0.408 -0.548 -0.512
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -103.238 -56.126 -35.888 -17.2681 -18.1728
    Cash From Operating Activities -70.985 -40.591 -21.914 -13.3573 -8.78791
    Cash From Operating Activities 2.457 0.08 0.023 0.01423 0.00979
    Non-Cash Items 30.512 16.875 13.868 3.96057 8.02881
    Changes in Working Capital -0.716 -1.566 0.083 -0.06393 1.34632
    Cash From Investing Activities -4.74 -3.716 -0.055 -0.0272 -0.02661
    Capital Expenditures -1.54 -1.469 -0.055 -0.0272 -0.02661
    Cash From Financing Activities 38.211 104.309 33.006 11.3816 15.5016
    Financing Cash Flow Items 1.916 -1.312 -0.1 -0.1011 -0.22567
    Issuance (Retirement) of Stock, Net 1.068 120.591 16.406 5.54744 13.7344
    Net Change in Cash -37.514 60.002 11.037 -2.00289 6.6871
    Issuance (Retirement) of Debt, Net 35.227 -14.97 16.7 5.93525 2
    Total Cash Dividends Paid 0 -0.0071
    Amortization 0.146
    Other Investing Cash Flow Items, Total -3.2 -2.247
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -22.214 -103.238 -78.666 -48.734 -19.633
    Cash From Operating Activities -16.287 -70.985 -54.162 -34.821 -12.263
    Cash From Operating Activities 0.727 2.457 1.731 1.031 0.093
    Non-Cash Items 6.962 30.512 25.477 14.616 5.016
    Changes in Working Capital -1.762 -0.716 -2.704 -1.734 2.138
    Cash From Investing Activities 0.974 -4.74 -4.442 -3.126 -0.574
    Capital Expenditures -0.026 -1.54 -1.242 -0.926 -0.574
    Cash From Financing Activities 24.849 38.211 38.131 25.842 0.316
    Financing Cash Flow Items 1.916 1.916 0 0
    Issuance (Retirement) of Stock, Net 14.924 1.068 0.988 0.842 0.316
    Issuance (Retirement) of Debt, Net 9.925 35.227 35.227 25 0
    Net Change in Cash 9.536 -37.514 -20.473 -12.105 -12.521
    Amortization 0.123
    Other Investing Cash Flow Items, Total 1 -3.2 -3.2 -2.2

    PAVmed Inc. Company profile

    PAVmed Inc. operates as a medical device company in the United States. The company''s lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett''s Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
    Industry: Advanced Medical Equipment & Technology (NEC)

    360 Madison Avenue
    25th Floor
    NEW YORK
    NEW YORK 10017
    US

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    Oil - Crude

    90.14 Price
    +0.770% 1D Chg, %
    Long position overnight fee 0.0415%
    Short position overnight fee -0.0634%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    XRP/USD

    0.52 Price
    +0.700% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    US100

    14,710.90 Price
    +0.190% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 7.0

    ETH/USD

    1,598.67 Price
    +0.440% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading